KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Treasury Shares (2016 - 2026)

CareDx's Treasury Shares history spans 12 years, with the latest figure at $4.9 million for Q1 2026.

  • On a quarterly basis, Treasury Shares fell 4.01% to $4.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $4.9 million, a 4.01% decrease, with the full-year FY2025 number at $3.9 million, down 18.83% from a year prior.
  • Treasury Shares hit $4.9 million in Q1 2026 for CareDx, up from $3.9 million in the prior quarter.
  • Over the last five years, Treasury Shares for CDNA hit a ceiling of $5.2 million in Q2 2023 and a floor of $335583.0 in Q2 2024.
  • Historically, Treasury Shares has averaged $3.2 million across 5 years, with a median of $3.1 million in 2022.
  • Biggest five-year swings in Treasury Shares: tumbled 93.53% in 2024 and later skyrocketed 1125.0% in 2025.
  • Tracing CDNA's Treasury Shares over 5 years: stood at $3.1 million in 2022, then surged by 61.8% to $5.0 million in 2023, then decreased by 3.28% to $4.8 million in 2024, then fell by 18.83% to $3.9 million in 2025, then increased by 23.49% to $4.9 million in 2026.
  • Business Quant data shows Treasury Shares for CDNA at $4.9 million in Q1 2026, $3.9 million in Q4 2025, and $5.0 million in Q3 2025.